The hyperinsulinemia and lower insulin sensitivity observed in our study participants in the absence of overt hyperglycemia suggest that FGFR1 signaling may be temporally implicated in the early insulin hypersecretory phase and insulin resistance seen in initial stages of T2D pathophysiology. This evidence concerns the gene FGFR1 and Insulin resistance.